WallStSmart

Lineage, Inc. Common Stock (LINE)vsLXP Industrial Trust (LXP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 1442% more annual revenue ($5.36B vs $347.70M). LXP leads profitability with a 18.7% profit margin vs -2.7%. LXP earns a higher WallStSmart Score of 44/100 (D).

LINE

Hold

36

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

LXP

Hold

44

out of 100

Grade: D

Growth: 3.3Profit: 6.0Value: 3.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.63

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

LXP1 strengths · Avg: 8.0/10
Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

LXP4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

PEG RatioValuation
3.152/10

Expensive relative to growth rate

P/E RatioValuation
61.1x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : LXP

The strongest argument for LXP centers on Price/Book. Profitability is solid with margins at 18.7% and operating margin at 16.1%.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : LXP

The primary concerns for LXP are Revenue Growth, Return on Equity, PEG Ratio. A P/E of 61.1x leaves little room for execution misses.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while LXP is a value play — different risk/reward profiles.

LXP carries more volatility with a beta of 1.07 — expect wider price swings.

LXP is growing revenue faster at 0.4% — sustainability is the question.

LXP generates stronger free cash flow (34M), providing more financial flexibility.

Bottom Line

LXP scores higher overall (44/100 vs 36/100), backed by strong 18.7% margins. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.

Visit Website →

LXP Industrial Trust

REAL ESTATE · REIT - INDUSTRIAL · USA

LXP Industrial Trust (LXP) is a prominent real estate investment trust (REIT) dedicated to the acquisition and management of industrial properties across key U.S. logistics markets. With the e-commerce sector's growth driving demand for efficient supply chains, LXP is strategically positioned to generate sustainable income and achieve capital appreciation. The company emphasizes a disciplined capital allocation strategy and maintains strong tenant relationships, supported by proactive asset management. By prioritizing operational excellence and staying attuned to market trends, LXP aims to enhance shareholder value and capitalize on growth opportunities within the industrial real estate sector.

Visit Website →

Want to dig deeper into these stocks?